Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
12
13
14
15
16
17
18
19
20
21
22
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
281
562
843
1124
1405
1686
1967
2248
2529
2810
AFM13/AB-101
/ Affimed, GC Biopharma
AFM28
/ Affimed
AFNT-111
/ Affini-T Therap, Erasca
AGEN1571
/ Agenus
AGEN2373
/ Agenus, Gilead
AK131
/ Akesobio
AL003
/ Alector
ALETA-001
/ Aleta Biotherap
ALG.APV-527
/ Alligator Biosci, Aptevo Therap
ALLO-501
/ Allogene Therap
ALM201
/ Almac Discovery
AMC303
/ amcure
AMG 172
/ Amgen
AMG 340
/ Amgen
AMG 562
/ Amgen
AMG 794
/ Amgen
AMT-116 ADC
/ Multitude Therap
AN4005
/ Adlai Nortye
APVO210
/ Aptevo Therap
APVO414
/ Aptevo Therap
ASC61
/ Ascletis
ASD141
/ BRIM Biotech
ASKG915
/ Aosaikang Pharma
ASP2074
/ Astellas
ASP2138
/ Astellas
ASP2802
/ Astellas
AT101
/ AbClon
ATG-037
/ Antengene
ATLCAR.CD138
/ UNC Lineberger Comprehensive Cancer Center
ATN-031
/ Antengene
AU-007
/ Aulos Biosci
AUR-103
/ Dr. Reddy’s
AUR-105
/ Dr. Reddy’s
AUR-106
/ Dr. Reddy’s
AUTO1/22
/ Autolus
AVA-001
/ Avalon GloboCare, BriSTAR Immunotech
AVC-001
/ AvenCell Therap, BMS
AVC-101
/ AvenCell Therap
AVC-201
/ AvenCell Therap
AVE9633
/ Sanofi
AWT020
/ Anwita Biosci
AZD5863
/ AstraZeneca
Ac225-DOTA-M5A
/ City of Hope, National Cancer Institute - Bethesda
Anti-CD19 CAR NK Cells
/ Allife Medical Science and Technology
Anti-CD19-CAR
/ Beijing Doing Biomedical
Anti-CD19/CD20/CD22 CAR T-Cells
/ The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Instit
Anti-CD22 CAR NK Cells
/ Allife Medical Science and Technology
Aurixim
(rituximab conjugate) / ChemRar
B1962
/ AP Biosciences
BA1106
/ Luye Group
«
1
2
...
12
13
14
15
16
17
18
19
20
21
22
...
27
28
»
